CAS: 32886-97-8; Pivmecillinam

该化合物是一种半合成抗生素,主要用于治疗易感染细菌引起的尿道感染,其化学结构的特点是存在乙酯环,这对抗菌活动至关重要;青霉素是一种青蒿素,意味着它被转化成体内的活性形式;青霉素是一种属于青霉素类的半合成抗生素,主要用于治疗由易感染细菌引起的尿道感染;该物质一般都得到良好的缓解,具有常见副作用,包括胃肠紊乱和敏感个人过敏反应;青霉素通常通过口头施用,并因其有利的药状皮肤特征而著称,包括良好的组织渗透和相对较长的半衰期;在抗生素抗药性令人关切的地区,使用该物质的情况特别显著,因为它为不相容的尿道感染提供了替代治疗选择.与所有抗生素一样,适当使用该物质对于最大限度地减少抗药性至关重要.

结构式图片

上下游产品

[(2,2-二甲基丙烷酰基)氧基]甲基6-氨基-3,3-二甲基-7-氧代-4-硫杂-1-氮杂双环[3.2.0]庚烷-2-羧酸酯 (Pivaloyloxy)Methyl 6β-Aminopenicillate 25031-08-7

合成工艺路线路线简述

    📜N-Formyl Cyclohexanone Dimethyl Sulfate Salt,[(2,2-二甲基丙烷酰基)氧基]甲基6-氨基-3,3-二甲基-7-氧代-4-硫杂-1-氮杂双环[3.2.0]庚烷-2-羧酸酯 反应 6.0H,以86.6%的收率获得产物匹美西林
    参考文献:一种一锅合成匹美西林的工艺
    标题:一种一锅合成匹美西林的工艺
    摘要:本发明公开了一种简易制备匹美西林的方法,该化合物是一种口服型广谱半合成青霉素,通过干扰细菌细胞壁生物合成而起抗菌作用.该方法采用一锅煮的工艺路线,以6‑apa为起始原料,经氧位烷基化,氮位亚胺化的方法合成匹美西林.本发明合成工艺简单,生产成本低,步骤少,总收率高,污染小,适合工业化大生产.

    海关参考信息

    专利信息


    专利号:US-9693999-B2
    优先权日:2011-01-26
    标题:Small molecule RNase inhibitors and methods of use
    发明人:DUNMAN PAUL M; OLSON PATRICK D; CHILDERS WAYNE
    权利人:UNIV ROCHESTER; UNIV NEBRASKA; Temple University—Of the Commonwealth System of Higher Education
    摘要:Small molecule inhibitors of bacterial ribonuclease (e.g., RnpA) and methods for their synthesis and use are described herein. The methods of using the compounds include treating and preventing microbial infections and inhibiting bacterial ribonuclease. Also described herein are methods of identifying compounds for treating or preventing a microbial infection.

    专利号:WO-2009056955-A1
    优先权日:2007-10-30
    标题 :Amine-bearing phospholipids (abps), their synthesis and use
    发明人:ZUMBUEHL ANDREAS
    权利人:UNIV BASEL; ZUMBUEHL ANDREAS
    摘要:Disclosed herein are amine-bearing phospholipids (ABP). The ABPs display many properties and functionalities of naturally occurring phospholipids, but also new properties and functionalities, such as the ability to polymerize while maintaining structural integrity, that may supplement or expand the functionalities of naturally occurring phospholipids.

    专利号:US-9868747-B2
    优先权日:2014-02-18
    标题:Marinopyrrole derivatives and methods of making and using same
    发明人:LI RONGSHI; SEBTI SAID; LIU YAN; QIN YONG; SONG HAO; CHENG CHUNWEI
    权利人:H LEE MOFFITT CANCER CT & RES; CHONGQING ZEIN PHARMACEUTICAL CO LTD
    摘要:Marinopyrrole derivatives and methods for their synthesis and use are described herein. Novel cyclic and symmetric marinopyrroles with triazole substituents having antibacterial activity against resistant bacterial strains, such as MRSA are introduced. Also provided are methods of using the compounds for treating or preventing cancer and/or microbial infections.

    专利号:US-2025002508-A1
    优先权日:2020-05-05
    标题 :Boronic acid derivatives and synthesis, polymorphic forms, and therapeutic uses thereof
    发明人:HECKER SCOTT J; BOYER SERGE HENRI; BIO MATTHEW M; FANG YUANQING; GONZALES DE CASTRO ANGELA; LEFORT LAURENT; ZHU ZUOLIN; LINDER THOMAS
    权利人:QPEX BIOPHARMA INC
    摘要:Disclosed herein are antimicrobial compounds, polymorphic forms, compositions, pharmaceutical compositions, the method of use and preparation thereof. Some embodiments relate to boronic acid derivatives and their use as therapeutic agents, for example, β-lactamase inhibitors (BLIs).

    专利号:US-9907753-B2
    优先权日:2010-03-19
    标 题 :Lipid vesicle compositions and methods of use
    发明人:IRVINE DARRELL J; MOON JAEHYUN
    权利人:MASSACHUSETTS INST TECHNOLOGY
    摘要:The invention provides delivery systems comprised of stabilized multilamellar vesicles, as well as compositions, methods of synthesis, and methods of use thereof. The stabilized multilamellar vesicles may comprise prophylactic, therapeutic and/or diagnostic agents.

    专利号:US-8933207-B2
    优先权日:2010-07-28
    标 题 :Drug-ligand conjugates, synthesis thereof, and intermediates thereto
    发明人:CHEN ZHIYU; LANCASTER THOMAS M; ZION TODD C
    权利人:CHEN ZHIYU; LANCASTER THOMAS M; ZION TODD C; SMARTCELLS INC
    摘要:The present invention relates to methods for synthesizing compounds of formula I or pharmaceutically acceptable salts thereof: I wherein each of X, Alk 1 , Alk 2 , and W are as defined and described herein.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Bader MS, Loeb M, Leto D, Brooks AA. Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents. Postgrad Med. 2020 Apr;132(3):234-250. doi: 10.1080/00325481.2019.1680052. Epub 2019 Oct 24. 46 Suppl
    1:35-9; discussion 63-5. Erratum in: J Antimicrob Chemother. 2008 Jul;62(1):215. 22 Suppl
    2:73-8. doi: 10.1016/s0924-8579(03)00235-8. 24(5):e2. doi: 10.1136/bmjebm-2018-111084. Epub 2018 Dec 5. 16(26):103-4. 53(8):612-7. 4(3):267-73. doi: 10.1111/j.1365-2125.1977.tb00711.x.

    合成参考文献


    参考文献:10.3238/arztebl.2011.0415
    摘要:Wagenlehner FM, Hoyme U, Kaase M, Fünfstück R, Naber KG, Schmiemann G. Uncomplicated urinary tract infections. Dtsch Arztebl Int. 2011 Jun;108(24):415–23.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知